Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Short Interest Update

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) was the recipient of a significant decrease in short interest during the month of January. As of January 31st, there was short interest totalling 2,940,000 shares, a decrease of 6.7% from the January 15th total of 3,150,000 shares. Based on an average daily trading volume, of 708,000 […]

Leave a Reply

Your email address will not be published.

Previous post Roivant Sciences Ltd. (NASDAQ:ROIV) Shares Sold by Louisiana State Employees Retirement System
Next post Summit Trail Advisors LLC Buys 7,711 Shares of Meta Platforms, Inc. (NASDAQ:META)